Earnings NewsHealthcareSalix Pharmaceuticals misses by $0.02, misses on revenueNov. 06, 2014 4:51 PM ETSalix Pharmaceuticals, Ltd. (SLXP) StockBy: SA News Team2 Comments Salix Pharmaceuticals (NASDAQ:SLXP): Q3 EPS of $1.53 misses by $0.02. Revenue of $354.72M (+48.9% Y/Y) misses by $37.64M. Shares -32.95%. Press Release Recommended For YouRelated StocksSymbolLast Price% ChgSLXP--Salix Pharmaceuticals, Ltd.Trending AnalysisTrending News